Abstract 24
Human cytomegalovirus (HCMV) manipulates many aspects of host cell biology to 25 create an intracellular milieu optimally supportive of its replication and spread. The current study 26 reveals a role for purinergic signaling in HCMV infection. The levels of several components of 27 the purinergic signaling system, including the P2Y2 receptor, were altered in HCMV-infected 28 fibroblasts. P2Y2 receptor RNA and protein are strongly induced following infection. 29
Pharmacological inhibition of receptor activity or knockdown of receptor expression markedly 30 reduced the production of infectious HCMV progeny. When P2Y2 activity was inhibited, the 31 accumulation of most viral RNAs tested and viral DNA was reduced. In addition, the level of 32 cytosolic calcium within infected cells was reduced when P2Y2 signaling was blocked. The 33 HCMV-coded UL37x1 protein was previously shown to induce calcium flux from the smooth 34 endoplasmic reticulum to the cytosol, and the present study demonstrates that P2Y2 function is 35 required for this mobilization. We conclude that P2Y2 supports the production of HCMV 36 progeny, possibly at multiple points within the viral replication cycle that interface with 37 signaling pathways induced by the purinergic receptor. 38 Introduction 70 Human cytomegalovirus (HCMV) is a beta herpesvirus that infects a large percentage of 71 the adult population worldwide. Infection in immunocompetent people is typically 72 asymptomatic. In contrast, HCMV is a leading opportunistic pathogen in immunosuppressed 73 individuals [1] [2] [3] [4] and is a major infectious cause of birth defects [5, 6] . 74 HCMV causes broad cellular effects that likely contribute to the diverse pathologies 75 associated with infection. One mechanism utilized by the virus to change the biology of infected 76 cells is via the regulation of expression levels and activities of cell surface proteins [7, 8] . Here, 77 we describe the role of purinergic receptors during HCMV infection. Purinergic receptors are 78 ubiquitous cell surface receptors that are activated by extracellular adenosine di-(ADP) and tri-79 (ATP) phosphates (P2 receptors) or adenosine (P1 receptors). P2 purinergic receptors are further 80 divided into ionotropic P2X and metabotropic P2Y families. P2X receptors are ATP-gated ion 81 channels and P2Y receptors are G protein-coupled receptors that are activated by adenine and 82 uridine nucleotides or nucleotide sugars. Seven subtypes of P2X receptors (P2X1-7) and eight of 83 P2Y receptors (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, and P2Y14) have been 84 identified [9, 10] . 85
Signaling via the P2Y receptors triggers the activation of a heterotrimeric G protein, 7 pathway downstream of P2Y2 signaling that is independent of PKC activation [42] . To test this 139 notion, we used pharmacological agents and siRNA technology to study the consequences of 140 inhibiting purinergic receptors during HCMV infection. We provide evidence that P2Y2 141 inhibition interferes with the expression of viral genes and the release of infectious progeny, 142
whereas P2X5 supplemented with 10% fetal bovine serum (FBS) . Penicillin and streptomycin were added to the 150 media for all experiments except those involving siRNA transfection. 151 HFF cells stably expressing the viral protein, pUL37x1, were made using the pLVX-152
EF1α promotor lentivirus packaging plasmid (Clontech). To insert AD169 UL37x1 between 153
EcoRI-BamHI sites of the pLVX-EF1 plasmid, the sequence was amplified by PCR from 154 BADwt, a BAC containing the AD169 strain [43] . Lentivirus particles were generated using 155 sequence-confirmed plasmids containing UL37x1 or GFP as a control. Following lentiviral 156 treatment, cells expressing pUL37x1 or GFP were selected using 2 µg/ml puromycin, and protein 10 from total RNA using biotinylated probes that selectively bind rRNA species. The resulting 210 rRNA-depleted RNA underwent fragmentation, reverse transcription, end repair, 3'-end 211 adenylation, adaptor ligation and subsequent PCR amplification and SPRI bead purification 212 (Beckman Coulter). The unique barcode sequences were incorporated in the adaptors for 213 multiplexed high-throughput sequencing. The final product was assessed for its size distribution 214 and concentration using BioAnalyzer High Sensitivity DNA Kit (Agilent) and Kapa Library 215 Quantification Kit (Kapa Biosystems). The libraries were pooled, denatured and loaded onto a 216
HiSeq Rapid Paired-Read flow cell (Illumina), which was subjected to 2X100 cycles of 217 sequencing by an Illumina HiSeq 2500 (Illumina). Illumina CASAVA pipeline Version 1.8 was 218 used to extract de-multiplexed sequencing reads. Sequencing reads were normalized using the 219 trimmed mean of M-values method (TMM), mapped to the human reference genome and 220 transcripts annotated to which reads have been mapped. Mapped reads were counted and the 221 differential gene expression between triplicate samples from mock-and HCMV-infected cells 222 was computed based on counts per million (CPM). Ingenuity Pathway Analysis cloud software 223 (Qiagen) was used to group the genes identified as significantly up-or down-regulated into gene 224 ontologies and to determine which cellular networks were the most significantly regulated in 225
HCMV-infected cells. 226
For quantitative reverse transcription PCR (qRT-PCR) analysis of RNA, RNA was 227 extracted from samples collected in QIAzol lysis reagent using the miRNeasy kit (Qiagen 
Results

263
HCMV infection elevates the steady-state levels of several purinergic receptors 264
To investigate the differential expression of purinergic receptors during infection, we 265 performed whole RNA sequencing of MRC-5 fibroblasts infected with the AD169 strain of 266 HCMV. RNA from mock and infected cells was analyzed in three independent experiments 267 where samples were collected at 48 hpi, allowing us to analyze RNAs during the late phase of 268 the viral replication cycle. Several components involved in purinergic receptor signaling are 269 expressed at significantly higher levels in the infected cells, including P2Y2, P2X5, ENPP4 and 270 ENTPD2, and several others were reduced (Table 2) . 271
To confirm the results obtained from RNA-Seq and extend the findings to a different 272 fibroblast cell population and virus strain, we used qRT-PCR to investigate the expression levels 273 of the RNAs identified in our RNA-seq analysis. HFFs were infected with the TB40/E-GFP 274 strain of HCMV at a multiplicity of 3 TCID 50 /cell. At 48 hpi, HCMV-infected cells expressed 275 76.41 ± 20.10 times more P2Y2, 2.74 ± 0.54 times more P2X5, 9.98 ± 3.22 times more ENPP4 276 and 45.55 ± 16.54 times more ENTPD2 RNA than mock-infected controls (Fig. 1) . 277
We also examined the kinetics of P2Y2 and P2X5 receptor expression throughout the 278 viral replication cycle. HFFs were infected at a multiplicity of 3 TCID 50 /cell, and samples were 279 collected after various time intervals. P2Y2 and P2X5 RNAs were assayed by qRT-PCR and 280 receptor proteins were assayed by Western blot. P2Y2 RNA was elevated at 24 hpi and increased 281 as the infection progressed ( Fig. 2A ). P2Y2 protein became highly abundant at 48 hpi and its 282 levels stayed elevated through the last time point assayed at 120 hpi (Fig. 2C ). These results also 283 qualitatively match the mass spectroscopy-based analysis of cell surface proteins, which 284 determined that P2Y2 protein is 3-, 4-and 5-fold more abundant at 24, 48, and 72 hpi, 285 respectively, compared to uninfected cells [8] . In the case of P2X5, its transcript levels increased 286 up to 48 hpi and then decreased later in infection ( Fig. 2B ). This corresponded with increasing 287 levels of P2X5 protein between 24 and 72 hpi, which then markedly decreased later in infection 288 ( Fig. 2C ). 289
Taken together, data from both RNA-Seq and qRT-PCR analyses confirm that HCMV 290 infection in fibroblasts causes an increase in the expression of the cellular purinergic receptors 291 P2Y2 and P2X5, as well as the cell surface ectonucleotidases ENPP4 and ENTPD2. 292
293
Viral gene expression is necessary for the normal modulation of P2Y2 and P2X5 expression 294
Since the overexpression of these receptors was seen during the early and late phases of 295 infection, we wished to determine whether the binding of the virion to the fibroblast cell surface 296 was sufficient to induce their upregulation. To do so, we used UV-irradiated TB40/E virus that 297 can bind to and enter cells but cannot express its genes. HFFs were infected with the untreated 298 virus or UV-irradiated virus at a multiplicity of 3 TCID 50 /cell, samples were collected at 24 and 299 48 hpi and receptor transcript levels were quantified by qRT-PCR. Compared to cells infected 300 with untreated TB40/E virus, those infected with the UV-irradiated virus exhibited 90% lower 301 expression of P2Y2 RNA (Fig. 3A ) but 40% higher expression of P2X5 ( Fig. 3B ). This finding suggests that viral binding and entry is not sufficient to produce the increased levels of P2Y2 303 transcript normally seen during infection. However, viral gene expression appears not to be 304 required for the upregulation of P2X5 expression. 305
306
P2Y2 and P2X5 receptors have opposite effects on HCMV yield 307
To determine whether the upregulated expression of these purinergic receptors and 308 ectonucleotidases is related to HCMV pathogenesis, we assessed the effects of inhibiting their 309 expression or activity on the production of infectious progeny. 310
First, we employed siRNAs to knock down their expression. Specific siRNAs designed to 311 target the P2Y2 (siP2Y2), P2X5 (siP2X5), ENPP4 (siENPP4) and ENTPD2 (siENTPD2) 312 transcripts were used to inhibit the expression of these four genes. We verified that the siRNAs 313 reduced expression of their targeted transcripts by using qRT-PCR ( Fig. 4A ). HFFs were 314 transfected with the selected siRNAs for 24 h before HCMV infection at a multiplicity of 3 315 TCID 50 /ml. At 120 hpi, the media was collected and viral titer assayed. Knockdown of the P2Y2 316 (~15% of its normal level) or P2X5 receptor (~10% of its normal level) reduced the viral yield 317 by ~95% or increased the yield by almost 400%, respectively ( Fig. 4B ), compared to viral titer of 318 the media collected from scrambled siRNA (siSc)-treated cells. In contrast, siRNA-mediated 319 knockdown of ENPP4 or ENTPD2 had minimal effects on the amount of infectious progeny 320 released by the infected cells ( Fig. 4B) . 321
Seeing the significant effect of P2Y2 and P2X5 knockdown on HCMV yield, we focused 322 further study on the roles of these two receptors. To investigate the kinetics of viral release 323 during infection, HFFs were transfected with selected siRNAs for 24 h before HCMV infection 324 at a multiplicity of 3 TCID 50 /cell. Differences in the amount of virus released from cells 325 transfected with siP2Y2 (reduced virus yield) or siP2X5 (increased virus yield) relative to 326 control cells transfected with siSc were first observed at 72 hpi and gradually increased up to 120 327 hpi ( Fig. 4C ). 328
We next employed pharmacological perturbations to confirm the roles of the receptors 329 during HCMV infection. Kaempferol is a selective P2Y2 receptor antagonist [17, 53] . PPADS 330 has ~10-fold higher affinity for blocking P2X5 than other P2X family members [23, 54] . We 331 used kaempferol and PPADS at 50 µM in our studies, because the drugs are commonly used to 332 treat fibroblasts at concentrations of 20-100 µM [55-58] and we detected little toxicity when 333 uninfected fibroblasts were treated at doses ranging from 0-400 µM (Fig. 5A, B) . To test the 334 effects of inhibiting P2Y2 and P2X5 receptor activity on the release of viral progeny, HFFs were 335 pretreated with drug for 1 h prior to HCMV infection at a multiplicity of 3 TCID 50 /cell. After 336 allowing 2 h for viral entry into cells, cells were washed and supplemented with media 337 containing either kaempferol or PPADS. Media with drug was replaced every 24 h until media 338 samples were collected at 96 hpi and assayed for infectious virus. Kaempferol decreased the viral 339 yield by more than 99%, whereas PPADS nearly tripled the yield (Fig. 5C ). Therefore, we 340 conclude that elevated P2Y2 receptor activity normally facilitates infection whereas the P2X5 341 receptor plays an antiviral role. 342 343 Inhibiting P2Y2 and P2X5 purinergic receptors does not affect the efficiency of viral entry 344 into fibroblasts. 345
We next aimed to elucidate the point during infection at which the two purinergic 346 receptors play a role. A possible explanation for the observed changes in viral yield upon 347 inhibiting the activity or expression of P2Y2 and P2X5 is that the cell surface purinergic receptors may function in the initial entry of the virus into fibroblasts. Although this notion did 349 not fit well with the kinetics of receptor expression following HCMV infection (Fig. 2) , 350 purinergic signaling was shown to be involved in the entry step for HIV-1 infection [17, 59] . 351 Therefore, we tested this possibility using both pharmacological antagonists and siRNA-352 mediated expression knockdown. First, we assessed the efficiency of viral entry into cells that 353 have been pre-treated with kaempferol or PPADS compared to solvent controls. Cells were 354 treated with drugs and after 1 h, cells were washed and HCMV-infected at a multiplicity of 1 355 TCID 50 /cell for 1 h at 4°C to allow virus attachment to the cell surface. Then, the viral particles 356 that did not attach were removed and cells were incubated at 37°C, allowing the attached virus to 357 penetrate the cells. After 24 h, the cells were fixed and immunostained for IE1 protein. Pre-358 treatment with either drug did not significantly alter the percentage of cells expressing IE1 359 protein compared to solvent controls ( Fig. 6A ). To confirm these results, we assessed the 360 efficiency of viral entry in cells transfected with siP2Y2, siP2X5 or siSc as a control. Cells were 361 transfected with the appropriate siRNA for 24 h before HCMV infection at a multiplicity of 1 362 TCID 50 /cell. After 1 h at 4°C, unattached virions were removed and cultures were shifted to 363 37°C. One hour later, samples were collected and viral DNA copy number was quantified by 364 qPCR. Again, results showed no significant differences in fold change of viral DNA copies 365 between the siP2Y2 or siP2X5 transfected cells and the siSc controls ( Fig. 6B ). We conclude that 366 inhibiting P2Y2 and P2X5 activity or expression does not affect viral entry into HFFs. 367 368
Inhibiting P2Y2 reduces the accumulation of viral transcripts 369
To probe when and how the cellular P2Y2 receptor might affect viral gene expression 370 subsequent to virus entry, we analyzed viral gene expression in siSc-and siP2Y2-treated cells at various times during the viral replication cycle. qRT-PCR was used to quantify transcript levels 372 for representatives of the three main classes of viral genes. The data show that infection in cells 373 transfected with siP2Y2 resulted in a reduction of immediate early (UL123, UL122), early 374 (UL26, UL54), and late (UL69, UL82, UL99) viral transcripts compared to siSc controls (Fig. 375 7A-B, D-H). Viral RNAs were most dependent on P2Y2 during the late phase of infection, 376 consistent with the timing of P2Y2 RNA accumulation (Fig. 2 ). Intriguingly, one viral transcript, 377 immediate early UL37x1, was expressed at higher levels in cells transfected with siP2Y2 than in 378 control cells ( Fig. 7C ). UL37x1 has been implicated in the mobilization of intracellular Ca 2+ 379 during infection [28, 30] . 380
381
P2Y2 receptor affects the efficiency of viral DNA synthesis 382
One of the strongest inhibitory effects of P2Y2 knockdown was seen on the accumulation 383 of RNA coding for the viral DNA polymerase, UL54 ( Fig. 7E ). Given its direct role in viral 384 DNA replication [60], we tested whether P2Y2 could have an impact on viral DNA (vDNA) 385 accumulation. Total DNA was isolated from HCMV-infected control and P2Y2-deficient cells 386 and vDNA copy numbers were measured by qPCR using primers specific to UL123. There were 387 about 5-fold fewer copies of vDNA in P2Y2-deficient cells than in control cells (Fig. 8A ). This 388 supports the hypothesis that P2Y2 inhibition prevents viral DNA accumulation by blocking viral 389 DNA synthesis. To confirm this result, we also compared the vDNA copy numbers in released 390 viral particles between siP2Y2-treated cells and siSc-treated controls. Similarly, when viral 391 genomic DNA was isolated from viral particles and quantified, there were also nearly 5 times 392 fewer copies of vDNA released from P2Y2-deficient cells compared to control cells (Fig. 8B) . 393
To confirm that lower viral DNA synthesis is the predominant explanation for the decrease in 394 infectious particles found in the media collected from P2Y2-deficient cells (Fig. 4B , C and 5C), 395 we decided to test the alternative hypothesis that progeny released from P2Y2 knockdown cells 396 are less infectious by investigating if there are any effects of P2Y2 inhibition on the infectivity of 397 virions. Accordingly, the ratios of vDNA copy number to infectious unit were calculated, and 398 there was no significant difference between the siP2Y2-treated cells and siSc controls (Fig. 8C) . 399 Therefore, the reduction in HCMV yield observed in the P2Y2 knockdown condition is caused 400 by reduced viral DNA synthesis and release of viral particles, and not by reduced infectivity of 401 the virions released from P2Y2-deficient cells. Taken together, it appears that P2Y2 is critical for 402 viral DNA synthesis. Inhibiting the P2Y2 receptor reduces viral DNA synthesis and causes a 403 drastic reduction in viral titer. 404 405 P2Y2 and UL37x1 cooperate to regulate intracellular Ca 2+ during infection 406
One of the most striking findings in our analysis of the role of purinergic receptors on 407 viral gene expression during HCMV infection is the fact that of all the viral genes studied, only 408 one was upregulated in the siP2Y2-treated cells compared to siSc-treated control cells (Fig. 7C) . 409
This was the transcript of the viral immediate early UL37x1 gene. Previously, UL37x1 has been 410 shown to be involved in the release of Ca 2+ from SER stores to increase cytosolic Ca 2+ 411 concentrations during infection [28, 30] . Interestingly, P2Y2 is a G-protein coupled receptor that, 412 when activated, leads to the downstream hydrolysis of PIP 2 into IP 3 , which is also known to 413 cause the release of Ca 2+ ions from SER stores [11, 61] . Because of the potential involvement of 414 P2Y2 in Ca 2+ homeostasis following infection, we investigated the effects of inhibiting P2Y2 415 expression on intracellular Ca 2+ levels. To do so, fibroblasts were infected with either wild-type 416
ADwt virus or ADsubUL37x1 virus lacking the UL37x1 gene at a multiplicity of 1 TCID 50 /cell 417 or mock infected, and cultures were treated 2 h later with kaempferol or solvent control. Using a 418 multiplicity of 1 TCID 50 /cell allowed us also to measure Ca 2+ levels in infected and uninfected 419 cells in the same experimental well. At 20 hpi, we used the fluorescence-based fluo-4 AM 420 calcium assay to compare the changes in intracellular Ca 2+ concentrations. We determined that 421 wild type virus caused ~2.5-fold increase in Ca 2+ levels compared to uninfected cells (Fig. 9A) . 422
We postulated that if P2Y2 contributes to elevated levels of Ca 2+ in infected cells, then we should 423 see a partial decrease of Ca 2+ levels in cells either infected with ADwt and treated with 424 kaempferol or infected with ADsubUL37x1. Instead, we saw that in both instances, Ca 2+ was 425 reduced almost to the level found in uninfected cells ( Fig. 9A ). Interestingly, Ca 2+ levels did not 426 decrease further in cells infected with ADsubUL37x1 and treated with kaempferol. Therefore, 427 these data imply that P2Y2 and pUL37x1 work together to elevate Ca 2+ levels during HCMV 428 infection and that the lack of either component prevents cells from increasing intracellular 429 calcium levels during infection. 430
To further test this hypothesis, we investigated the effect of UL37x1 expression on Ca 2+ 431 homeostasis in HFF cells without the background of infection. For this purpose, a UL37x1-432 expressing lentiviral pLVX-EF1 plasmid was created. HFF cells were transduced with the vector, 433 and subjected to puromycin selection. Two cellular clones were obtained [pLVX-UL37x1(1) and 434 pLVX-UL37x1(2)] that exhibited stable expression of pUL37x1. The cells were treated with 435 kaempferol or solvent control for 1 h. Then, Ca 2+ levels were measured using the fluo-4 AM 436 assay and compared to levels in wild type HFF cells. No significant changes in Ca 2+ levels were 437 observed between samples (Fig. 9B) , which supports our conclusion that increased expression of 438 pUL37x1 in the absence of P2Y2 overexpression is not sufficient to stimulate the robust increase 439 in calcium seen in HCMV-infected cells. 440
As a control, cells transduced with pLVX-UL37x1 or pLVX-GFP plasmids were 441 analyzed by Western blot assay for the level of pUL37x1 expression. The assay confirmed the 442 pUL37x1 overexpression only in pLVX-UL37x1 plasmid-transduced HFF cells (Fig. 9C) . 443
Because inhibiting the P2Y2 receptor activity decreases the extent to which intracellular Ca 2+ is 444 mobilized during infection, we propose that P2Y2 signaling plays a critical role in controlling 445 intracellular Ca 2+ during HCMV infection. 446
Since previous studies as well as our current study have shown that the viral pUL37x1 447 protein is involved in the mobilization of intracellular Ca 2+ from calcium stores in the SER and 448 knowing that P2Y2 expression was upregulated early in infection, we aimed to further elucidate 449 the relationship between the viral UL37x1 and cellular P2Y2. Specifically, we assessed whether 450 the upregulation of P2Y2 expression during viral infection may be a downstream effect of the 451 immediate early kinetics of UL37x1 expression [62] . Since the upregulation of P2Y2 transcript is 452 most evident around 48hpi, it is conceivable that the viral pUL37x1 protein increases the 453 expression of P2Y2 and that increased P2Y2 activity further increases intracellular Ca 2+ levels 454 for the remainder of the infection. In order to test this idea, HFFs were infected with either the 455 ADsubUL37x1 virus or the wild type ADwt virus. Samples were collected at 24 hpi. P2Y2, 456 UL54, UL123 and UL37x1 transcript levels were quantified by qRT-PCR. If the hypothesis that 457 P2Y2 upregulation is dependent on pUL37x1 expression were true, then P2Y2 transcripts would 458 be significantly lower in cells infected with ADsubUL37x1 than ADwt virus. However, although 459 P2Y2 expression was appeared somewhat lower in cells infected with ADsubUL37x1 compared 460 to those infected with ADwt, the difference was not significant (Fig. 10A ). Interestingly, it was 461 also noted that unlike siP2Y2-treated cells, ADsubUL37x1-infected cells did not exhibit lower 462 UL54 RNA levels compared to ADwt-infected cells (Fig. 10B) . The same expression levels of UL123 in cells infected with either ADwt or ADsubUL37x1 confirm that the cells received an 464 equal amount of virus (Fig. 10C ). As expected, UL37x1 expression was only evident in and not in ADsubUL37x1-infected cells (Fig. 10D ). Both clonal populations of cells expressing 466 pUL37x1 were characterized by a robust expression of pUL37x1, but there was only a minimally 467 higher level of P2Y2 protein in these cells compared to controls expressing GFP (Fig. 9C) . 468
Therefore, these data suggest that viral pUL37x1 is likely not a significant upstream activator of 469 P2Y2 expression. 470
Taken together, these findings suggest that both cellular P2Y2 and viral pUL37x1 471 cooperate to modulate intracellular Ca 2+ within HCMV-infected cells. 472
473
Discussion
474
The purpose of this study was to investigate the role of purinergic signaling during 475 HCMV infection in human fibroblasts. RNA-Seq analysis identified several members of the 476 purinergic receptor network whose expression was modulated upon infection (Table 2) . qRT-477 PCR analysis confirmed that infection increased the cellular P2Y2, P2X5, ENPP4 and ENTPD2 478 transcripts. Elevated expression of purinergic receptors during HCMV infection has been 479 reported previously. In myeloid cells, HCMV infection increases the expression of the P2Y5 480 receptor [63] . In endothelial cells, HCMV infection has been associated with higher levels of the 481 P2Y2, P2Y1, and P2X7 receptors, as well as ecto-5'nucleotidase CD73 [25, 26] . Yet, the impact 482 of these altered expression patterns on the efficiency of HCMV infection has not been 483 investigated. We now report that siRNA targeting ENPP4 and ENTPD2 transcripts did not affect 484 viral yield (Fig, 4B) . In contrast, inhibiting the activity or expression of P2Y2 and P2X5 485 receptors had a robust effect on the amount of infectious progeny released from infected cells ( Fig. 4B, C) . These findings suggest that, at least in fibroblasts, purinergic signaling through the 487 P2Y2 and P2X5 receptors is important in HCMV infection independent from the activity of 488 ectonucleotidases. 489 Inhibiting P2Y2 and P2X5 by using pharmacological compounds or siRNA technology 490 drastically altered HCMV yield. It is noteworthy that, even though both receptors are activated 491 by ATP, they had completely opposite effects on the production of HCMV progeny. Compared 492 to control treated cells, infection in P2Y2-deficient cells led to a drastic reduction (~95% lower) 493 in the number of infectious virions released (Fig. 4B, C) , which demonstrated that P2Y2 supports 494 HCMV replication. On the other hand, infection in P2X5-deficient cells resulted in enhanced (4x 495 higher) viral release compared to control treated cells (Fig. 4B, C ), suggesting that P2X5 496 antagonizes HCMV replication. 497
Our analysis of P2Y2 and P2X5 expression kinetics supported the view that these 498 receptors are independently regulated and have different functions during HCMV infection. 499
While active viral gene expression is necessary for the upregulation of P2Y2 expression ( Fig.  500   3A) , it is not for the increased expression of P2X5 (Fig. 3B) . Moreover, P2Y2 gradually 501 increased in expression from 2 to 96 hpi, as seen at both RNA and protein levels ( Fig. 2A, C) , 502 P2X5 expression increased up to 48 hpi (RNA) or 72 hpi (protein) and then decreased 503 immediately afterwards (Fig. 2B, C) . The gradual increase in P2Y2 expression is consistent with 504 a supportive role for the receptor throughout the viral replication cycle. Conversely, the initial 505 spike in the levels of the inhibitory P2X5 receptor might be antagonized by a virus-mediated 506 mechanism that suppresses its expression later after infection. 507
How do the P2Y2 and P2X5 receptors modulate HCMV replication? The P2X5 508 purinergic receptor is a non-selective cation channel that is gated by extracellular ATP. It is 509 typically found on cells of the skin, gut, bladder, thymus, skeletal muscle, and spinal cord and is 510 thought to play important roles in cell differentiation [64] . For instance, it has been shown to be 511 involved in the differentiation of skin keratinocytes and mucosal epithelial cells during turnover 512 in the gut and bladder [19, 65] . P2X5 receptors have also been observed to play various roles in 513 regulating osteoblastic differentiation and proliferation, triggering differentiation of skeletal 514 muscle satellite cells, and the differentiation of human fetal epidermis [66, 67] . Although the 515 expression of P2X5 receptors have been associated with differentiating and proliferating cell 516 types, the exact mechanism by which its signaling affects these cellular processes is still unclear. 517
Thus it is difficult to speculate on how a block to its activity might influence HCMV replication. 518 P2Y2 is a G-protein coupled receptor that can be activated by extracellular ATP and 519 UTP. HCMV infection of P2Y2 knockdown cells exhibited reduced expression of most viral 520 genes tested, including UL54, the viral DNA polymerase catalytic subunit (Fig. 7E ). Reduced 521 pUL54 levels would be expected to reduce key downstream events in the viral replication cycle. 522
Indeed, P2Y2-deficient cells exhibited reduced accumulation of viral DNA (Fig. 8A ) and late 523 viral RNAs (Fig. 7F-H) . Although it is likely that the receptor has additional effects on HCMV 524 replication, its effect on viral DNA accumulation, followed by inhibition of late RNAs that 525 depend on active DNA replication for their synthesis, can explain the low viral yield from P2Y2-526 deficient cells. 527
There are several plausible mechanisms by which purinergic signaling via the P2Y2 528 receptor can affect viral DNA replication. It could affect DNA replication indirectly, through 529 inhibition of an upstream viral function that we have not yet measured, or it could act directly at 530 DNA replication. One potential mechanism is through p38 mitogen-activated protein kinases 531 (MAPKs). Extracellular ATP and UTP can activate the MAPK kinase (MKK) 3/6-p38-MAPK 532 cascade via the P2Y2 receptor in glomerular mesangial cells [68] . p38 activation results from 533 increased activity of MKK3/6, which are downstream effectors of P2Y2 signaling [69] . It has 534 been reported that active p38 plays a critical role in HCMV viral DNA replication in infected 535 human fibroblasts [69] . Thus, inhibiting P2Y2 could decrease MKK3/6 activity, which might 536 then reduce p38 activation and viral DNA replication. This role for P2Y2 action within infected 537 cells remains speculative, because the exact mechanism by which p38 regulates viral DNA 538 replication via the UL54 polymerase has not yet been characterized. 539
In addition to its impact on p38 MAPK, the P2Y2 receptor has a well-established role in 540 regulating cellular calcium levels [15, 16, 23] . Extracellular nucleotides act via the P2Y2 541 receptor to induce intracellular Ca 2+ mobilization from SER in a variety of cell types [70] [71] [72] . 542
The increase in intracellular Ca 2+ can be blocked by PLC inhibitors and by low molecular weight 543 heparin, indicating the involvement of IP 3 -sensitive intracellular Ca 2+ stores, which is known to 544 be downstream of P2Y2-mediated signaling [73] . As calcium homeostasis was found to be 545 critical for an efficient HCMV infection [27, 28] , it was intriguing to speculate that P2Y2 546 inhibition may have important consequences for HCMV replication due to disruption of 547 intracellular calcium regulation. Treating infected cells with drugs that disrupt SER Ca 2+ 548 homeostasis inhibits the production of infectious progeny due to retarded accumulation of late 549 gene products [27] , patterns that were observed during HCMV infection in P2Y2 knockdown 550
cells. 551
The first indication that P2Y2-dependent Ca 2+ regulation may be important during 552 HCMV infection came from analyzing differential expressions of viral genes in wild type cells 553 and cells treated with siP2Y2. Among all tested viral transcripts only UL37x1 RNA levels were 554 upregulated in P2Y2-deficient cells (Fig. 7C) . It is known that the HCMV immediate early 555 protein pUL37x1 induces the mobilization of Ca 2+ from the SER to the cytosol [28] . In addition, 556 the Ca 2+ -dependent protein kinase, PKCα, is activated following infection, leading to the 557 production of large (1-5 µm diameter) cytoplasmic vesicles late after infection [30] . The 558 presence of these vesicles correlated with the efficient accumulation of enveloped virions. 559
Regulating intracellular Ca 2+ levels may also influence viral DNA replication. Ca 2+ can induce 560 the activity of Ca 2+ /calmodulin-dependent protein kinase kinase (CaMKK), which activates 561 AMPK. AMPK activity has been shown to be necessary for HCMV DNA synthesis and the 562 expression of viral late genes [33, 34] . In addition, it has been found that extracellular 563 nucleotides stimulate the PI3-K/Akt pathway through P2Y2-mediated signaling involving Ca 2+ 564 influx, CaM, and Src [74] . It was previously reported that treating infected fibroblasts with an 565 inhibitor of PI3-K activity caused inhibition of viral DNA replication and a 4-log decrease in 566 viral titers [36] . Although intriguing, it is more likely that P2Y2-mediated inhibition of viral 567 UL54 is independent from its effects on intracellular Ca 2+ . Cells infected with ADsubUL37x1, 568 which lacks the UL37x1 gene, show reduced intracellular Ca 2+ levels (Fig. 9A) , but, 569 nevertheless, do not show reduced UL54 RNA levels (Fig. 10B ). Hence the effect P2Y2 on viral 570 DNA accumulation may be distinct from its effects on intracellular Ca 2+ concentrations. 571
To broaden our understanding on a potential role of P2Y2 in Ca 2+ levels and the 572 relationship between P2Y2 and UL37x1 during infection, we tested the effect of kaempferol, a 573 P2Y2 antagonist, on intracellular Ca 2+ in cells infected with wild-type HCMV (ADwt) versus the 574 pUL37x1-deficient mutant virus (ADsubUL37x1). As shown previously [28] , ADwt-infected 575 cells exhibited increased free Ca 2+ compared to uninfected cells, whereas ADsubUL37x1-576 infected cells had Ca 2+ levels similar to those in uninfected cells (Fig. 9A) . Interestingly, 577 kaempferol treatment also lowered Ca 2+ levels in ADwt-infected cells to its level in uninfected 578 cells and similar Ca 2+ levels were measured in kaempferol-treated, ADsubUL37x1-infected cells 579 ( Fig. 9A) . Additionally, when we tested Ca 2+ levels in uninfected cells that overexpress UL37x1, 580 no elevated levels of Ca 2+ were observed (Fig. 9B) . While P2Y2-deficient cells were 581 characterized by increased expression of UL37x1 (Fig. 7C) , neither ADsubUL37x1-infected 582 cells nor cells overexpressing UL37x1 affected P2Y2 RNA or protein levels (Fig.10A, 9C) . 583
Taken together, these results strongly suggest that P2Y2 has a critical role in regulating Ca 2+ 584 levels following HCMV infection. Both P2Y2 and pUL37x1 are indispensable for maintaining 585 favorable intracellular Ca 2+ levels during infection. It is not yet clear how the viral and cellular 586 gene products cooperate in this process. 587
Aside from disrupting viral DNA replication and Ca 2+ homeostasis, a third mechanism by 588 which P2Y2 activation may play a role in HCMV infection is through affecting the nuclear 589 egress of the viral capsid. It has been reported that PKC, a downstream effector of P2Y2 590 signaling, plays an important role in destabilizing the nuclear lamina by phosphorylating several 591 types of nuclear lamin [75] . The phosphorylation and reorganization of the nuclear lamins is an 592 essential part of viral nuclear egress [75] . It is conceivable, then, that a block to nuclear egress of 593 HCMV capsids could contribute to the reduction in infectious virus produced following 594 cell proliferation [77] . Since P2Y2 is dramatically overexpressed in HCMV-infected cells, it 602 would be interesting to understand how the expected upregulation of cellular DNA synthesis and 603 cell cycle progression is avoided in HCMV-infected cells in order to maintain the cell cycle 604 arrest characteristic of infection [78, 79] . 605
Signaling via the P2Y2 receptor also may influence cell migration. P2Y2 activation 606 increases MCF-7 breast cancer cell migration via the MEK-ERK 1/2 signaling pathway [80] . 607
Specifically, extracellular ATP can activate MAPKs through the P2Y2/PLC/PKC/ERK signaling 608 pathway to induce the translocation of ERK 1/2 into the nucleus [13] . Also, fibroblasts appear to 609 require PKC activation, which is downstream of P2Y2 signaling, in order to respond to 610 hyaluronan stimulation with increased locomotion [81] . Taken together, it is conceivable that the 611 overexpression of P2Y2 receptors during HCMV infection may lead to increased migration of 612 the host cell. This not only has potential to facilitate dissemination of the virus within its infected 613 host, it may also contribute to the likely oncomodulatory activity of HCMV [82] . 614
In summary, our results show that purinergic signaling through the P2Y2 and P2X5 615 receptors plays a critical role within infected cells and set the stage for additional investigations 616 on the impact of this receptor family in HCMV biology. Further, our observation that a 617 pharmacological block to P2Y2 dramatically reduces viral yield raises the possibility that P2Y2 618 antagonists, if well tolerated, could prove to be attractive candidates for new HCMV therapies. 619 620 Acknowledgments: 
